Your browser doesn't support javascript.
loading
Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel.
Russell, Matthew R; Graham, Ciaren; D'Amato, Alfonsina; Gentry-Maharaj, Aleksandra; Ryan, Andy; Kalsi, Jatinderpal K; Whetton, Anthony D; Menon, Usha; Jacobs, Ian; Graham, Robert L J.
Afiliación
  • Russell MR; Stoller Biomarker Discovery Centre and Manchester Molecular Pathology Innovation Centre, Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.
  • Graham C; School of Biological Sciences, Queens University Belfast, Chlorine Gardens, Belfast, BT9 5DL, UK.
  • D'Amato A; Department of Pharmaceutical Sciences, University of Milan, Milano, Lombardy, Italy.
  • Gentry-Maharaj A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, Faculty of Population Health Sciences, University College London, London, UK.
  • Ryan A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, Faculty of Population Health Sciences, University College London, London, UK.
  • Kalsi JK; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, Faculty of Population Health Sciences, University College London, London, UK.
  • Whetton AD; Stoller Biomarker Discovery Centre and Manchester Molecular Pathology Innovation Centre, Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.
  • Menon U; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, Faculty of Population Health Sciences, University College London, London, UK.
  • Jacobs I; Stoller Biomarker Discovery Centre and Manchester Molecular Pathology Innovation Centre, Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK. i.jacobs@unsw.edu.au.
  • Graham RLJ; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, Faculty of Population Health Sciences, University College London, London, UK. i.jacobs@unsw.edu.au.
Br J Cancer ; 121(6): 483-489, 2019 09.
Article en En | MEDLINE | ID: mdl-31388184
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Proteínas Sanguíneas / Biomarcadores de Tumor / Antígeno Ca-125 / Detección Precoz del Cáncer / Carcinoma Epitelial de Ovario / Fosfatidilcolina-Esterol O-Aciltransferasa Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Proteínas Sanguíneas / Biomarcadores de Tumor / Antígeno Ca-125 / Detección Precoz del Cáncer / Carcinoma Epitelial de Ovario / Fosfatidilcolina-Esterol O-Aciltransferasa Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido